SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-018616
Filing Date
2021-08-05
Accepted
2021-08-05 07:11:49
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20210630b_10q.htm   iXBRL 10-Q 850969
2 EXHIBIT 31.1 ex_252161.htm EX-31.1 12124
3 EXHIBIT 31.2 ex_252162.htm EX-31.2 12180
4 EXHIBIT 32.1 ex_252163.htm EX-32.1 5659
5 EXHIBIT 32.2 ex_252164.htm EX-32.2 5715
  Complete submission text file 0001437749-21-018616.txt   4412024

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20210630.xsd EX-101.SCH 41866
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20210630_cal.xml EX-101.CAL 28065
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20210630_def.xml EX-101.DEF 319114
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20210630_lab.xml EX-101.LAB 270370
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20210630_pre.xml EX-101.PRE 335560
11 EXTRACTED XBRL INSTANCE DOCUMENT arav20210630b_10q_htm.xml XML 589273
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 211146277
SIC: 2834 Pharmaceutical Preparations